Abstract

Classical genetic studies show the heritability of cigarette smoking is 0.4–0.6, and that multiple genes confer susceptibility and resistance to smoking. Despite recent advances in identifying genes associated with smoking behaviors, the major source of this heritability and its impact on susceptibility and resistance are largely unknown. Operant self-administration (SA) of intravenous nicotine is an established model for smoking behavior. We recently confirmed that genetic factors exert strong control over nicotine intake in isogenic rat strains. Because the processing of afferent dopaminergic signals by nucleus accumbens shell (AcbS) is critical for acquisition and maintenance of motivated behaviors reinforced by nicotine, we hypothesized that differential basal gene expression in AcbS accounts for much of the strain-to-strain variation in nicotine SA. We therefore sequenced the transcriptome of AcbS samples obtained by laser capture microdissection from 10 isogenic adolescent rat strains and compared all RNA transcript levels with behavior. Weighted gene co-expression network analysis, a systems biology method, found 12 modules (i.e., unique sets of genes that covary across all samples) that correlated (p<0.05) with amount of self-administered nicotine; 9 of 12 correlated negatively, implying a protective role. PCR confirmed selected genes from these modules. Chilibot, a literature mining tool, identified 15 genes within 1 module that were nominally associated with cigarette smoking, thereby providing strong support for the analytical approach. This is the first report demonstrating that nicotine intake by adolescent rodents is associated with the expression of specific genes in AcbS of the mesolimbic system, which controls motivated behaviors. These findings provide new insights into genetic mechanisms that predispose or protect against tobacco addiction.

Highlights

  • Genetic factors are pivotal determinants of vulnerability to cigarette smoking

  • Recent genome-wide association studies (GWAS) have identified several polymorphisms that are strongly correlated with smoking phenotypes

  • Like many GWAS studies of complex traits, these polymorphisms only explain a small fraction of the variation in smoking behavior [8,9], implicating a large number of unidentified genetic variations in the vulnerability to smoke tobacco

Read more

Summary

Introduction

Genetic factors are pivotal determinants of vulnerability to cigarette smoking. In classical genetic studies, the heritability of various smoking behaviors ranges between 0.4–0.6 [1,2,3]. Recent genome-wide association studies (GWAS) have identified several polymorphisms that are strongly correlated with smoking phenotypes (e.g., number of cigarettes smoked per day). Like many GWAS studies of complex traits, these polymorphisms only explain a small fraction of the variation in smoking behavior [8,9], implicating a large number of unidentified genetic variations in the vulnerability to smoke tobacco. The operant self-administration (SA) of intravenous (i.v.) nicotine, which achieves pharmacokinetic profiles [12,13] and plasma levels of nicotine [14] similar to those found in human smokers, has been used to model many nicotine behavioral phenotypes associated with dependence. Varenicline, a smoking cessation drug, has been shown to reduce rodent nicotine self-administration and drug seeking [25], providing further validation of the model

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.